U.S. market Closed. Opens in 12 hours 1 minute

GTHX | G1 Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
Revenue82.51M51.30M31.48M45.28MN/AN/AN/AN/A522.00K1.04M
Cost of Revenue7.20M3.75M2.02MN/A356.00K175.00K89.00K67.23K12.73M5.02M
Gross Profit75.32M47.55M29.46M45.28M-356.00K-175.00K-89.00K-67.23K-12.21M-3.98M
Operating Expenses114.84M183.73M171.92M141.76M129.04M89.29M60.97M30.39M15.95M2.70M
Selling, General & Admin71.13M100.42M95.69M68.49M40.04M18.60M7.09M5.23M3.22M2.70M
Research & Development43.71M83.32M76.22M73.27M89.00M70.68M53.88M25.16M12.73M5.02M
Other Operating Expenses2.24M3.00K-346.00K-542.00K6.59M4.00M888.00K182.37K18.00KN/A
Operating Income-39.53M-136.18M-142.46M-96.48M-129.04M-89.29M-60.97M-30.39M-15.42M-6.68M
Other Expenses / Income-5.33M-9.68M-4.97M-1.37M6.59M4.00M847.00K100.14K-4.84M-64.00
Before Tax Income-44.85M-145.86M-147.43M-97.84M-122.45M-85.29M-60.12M-30.29M-20.26M-6.68M
Income Tax Expenses3.12M1.70M925.00K1.41M-356.00K4.00M41.00K82.23K4.86M502.36K
Net Income-47.97M-147.56M-148.35M-99.25M-122.09M-85.29M-60.12M-30.29M-20.26M-7.18M
Interest Expenses10.04M10.43M4.67M1.78MN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding51.73M43.63M41.94M37.88M37.50M33.32M18.20M20.43M20.43M1.23M
Diluted Shares Outstanding51.73M43.63M41.94M37.88M37.50M33.32M18.20M20.43M20.43M1.23M
EBITDA-39.01M-134.90M-142.46M-95.48MN/AN/AN/A-30.32M-15.38M-6.66M
EBITDA Margin-47.28%-262.95%-452.59%-210.85%0.00%0.00%0.00%0.00%-2,946.74%-638.80%
EBIT-34.81M-135.43M-142.76M-96.07M-122.45M-81.29M-60.08M-30.21M-15.41M-6.68M
EBIT Margin-42.19%-263.99%-453.55%-212.14%0.00%0.00%0.00%0.00%-2,951.34%-640.46%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙